BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36945185)

  • 1. Nonparametric estimation of marked survival data in the presence of dependent censoring.
    Sanusi B; Cai J; Hudgens MG
    Stat Med; 2023 May; 42(12):1995-2008. PubMed ID: 36945185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonparametric estimation of the joint distribution of a survival time subject to interval censoring and a continuous mark variable.
    Hudgens MG; Maathuis MH; Gilbert PB
    Biometrics; 2007 Jun; 63(2):372-80. PubMed ID: 17688489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model selection for survival individualized treatment rules using the jackknife estimator.
    Honvoh GD; Cho H; Kosorok MR
    BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
    Hsu CH; Taylor JM; Hu C
    Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable selection using inverse probability of censoring weighting.
    Kojima M
    Stat Methods Med Res; 2023 Nov; 32(11):2184-2206. PubMed ID: 37675496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse probability weighted estimators of vaccine effects accommodating partial interference and censoring.
    Chakladar S; Rosin S; Hudgens MG; Halloran ME; Clemens JD; Ali M; Emch ME
    Biometrics; 2022 Jun; 78(2):777-788. PubMed ID: 33768557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonparametric regression with right-censored covariate via conditional density function.
    Jiang H; Huang L; Xia Y
    Stat Med; 2022 May; 41(11):2025-2051. PubMed ID: 35124839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric estimation in an illness-death model with component-wise censoring.
    Eaton A; Sun Y; Neaton J; Luo X
    Biometrics; 2022 Sep; 78(3):1168-1180. PubMed ID: 33914913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.
    Fukuda M; Sakamaki K; Oba K
    Clin Trials; 2023 Dec; 20(6):670-680. PubMed ID: 37455538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation with interval censored data and covariates.
    Van der Laan MJ; Hubbard A
    Lifetime Data Anal; 1997; 3(1):77-91. PubMed ID: 9384627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized mean residual life models for survival data with missing censoring indicators.
    Li W; Ma H; Faraggi D; Dinse GE
    Stat Med; 2023 Feb; 42(3):264-280. PubMed ID: 36437483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
    Latimer NR; Abrams KR; Siebert U
    BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of integrated transition hazards and stage occupation probabilities for non-Markov systems under dependent censoring.
    Datta S; Satten GA
    Biometrics; 2002 Dec; 58(4):792-802. PubMed ID: 12495133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Kawahara T; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.
    Schaubel DE; Wei G
    Biometrics; 2011 Mar; 67(1):29-38. PubMed ID: 20560935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous marginal survival estimators when doubly censored data is present.
    Julià O; Gómez G
    Lifetime Data Anal; 2011 Jul; 17(3):347-72. PubMed ID: 20886370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doubly robust nonparametric instrumental variable estimators for survival outcomes.
    Lee Y; Kennedy EH; Mitra N
    Biostatistics; 2023 Apr; 24(2):518-537. PubMed ID: 34676400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the survival function based on the semi-Markov model for dependent censoring.
    Zhao Z; Zheng M; Jin Z
    Lifetime Data Anal; 2016 Apr; 22(2):161-90. PubMed ID: 25772373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric estimation of the concordance correlation coefficient under univariate censoring.
    Guo Y; Manatunga AK
    Biometrics; 2007 Mar; 63(1):164-72. PubMed ID: 17447941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.